Hydrochloric Acid

Hydrochloric Acid

SCHEMBL638941

C=C(N)C(=O)O.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30317763 0.96 LDHA (0.54)
SCHEMBL124640 0.96
SCHEMBL29091411 0.92
Oxygen SCHEMBL11880058 0.92
SCHEMBL29091410 0.92
SCHEMBL28195865 0.92
Acetic Acid SCHEMBL28723159 0.85 TDP1 (0.53)
SCHEMBL28446532 0.82 LDHA (0.41)
Methacrylic Acid SCHEMBL11026953 0.82 TDP1 (0.59)
Acrylic Acid SCHEMBL18173808 0.79 LMNA (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230404896-A1 Styling Shampoo Compositions BASF SE (DE) 2023-12-21 US disclosed
EP-4240316-A1 STYLING SHAMPOO COMPOSITIONS BASF SE (DE) 2023-09-13 EP disclosed
WO-2022096243-A1 STYLING SHAMPOO COMPOSITIONS BASF SE (DE) 2022-05-12 WO disclosed
EP-2332583-B1 ANTIVIRAL DISINFECTANTS AND THEIR APPLICATIONS GOJO IND INC (US) 2018-12-19 EP disclosed
US-10130655-B2 Composition and method for pre-surgical skin disinfection GOJO INDUSTRIES, INC. (US) 2018-11-20 US disclosed
US-20170224722-A1 COMPOSITION AND METHOD FOR PRE-SURGICAL SKIN DISINFECTION GOJO INDUSTRIES, INC. (US) 2017-08-10 US disclosed
US-9629361-B2 Composition and method for pre-surgical skin disinfection GOJO INDUSTRIES, INC. (US) 2017-04-25 US disclosed
CN-104558406-B Preparation method of amphoteric polyacrylamide dispersion liquid 江苏富淼科技股份有限公司 2017-01-25 CN disclosed
EP-2471559-B1 Antiviral method GOJO IND INC (US) 2014-11-26 EP disclosed
US-8580860-B2 Foamable alcoholic composition GOJO INDUSTRIES, INC. (US) 2013-11-12 US disclosed
EP-1967576-A1 Foamable alcoholic composition Gojo Industries, Inc. (US) 2008-09-10 EP disclosed
US-20080207767-A1 Foamable Alcoholic Composition SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2008-08-28 US disclosed
CN-101023909-A Composition and method for pre-surgical skin disinfection GOJO IND INC (US) 2007-08-29 CN disclosed
WO-2007095008-A2 ANTIVIRAL DISINFECTANTS AND APPLICATIONS GOJO INDUSTRIES, INC. (US) 2007-08-23 WO disclosed
EP-1820396-A1 Composition and method for pre-surgical skin disinfection Gojo Industries, Inc. (US) 2007-08-22 EP disclosed
US-20070185216-A1 ANTIVIRAL METHOD PNC BANK, NATIONAL ASSOCIATION, AS AGENT 2007-08-09 US disclosed
US-20070184013-A1 Antiviral method SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2007-08-09 US disclosed
US-20070184016-A1 Composition and method for pre-surgical skin disinfection SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2007-08-09 US disclosed
EP-1811013-A1 Foamable alcoholic composition Gojo Industries, Inc. (US) 2007-07-25 EP disclosed
US-20070148101-A1 Foamable alcoholic composition GOJO INDUSTRIES, INC. 2007-06-28 US disclosed